These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 16474148)

  • 21. Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.
    Chang KS; Jiang J; Cai Z; Luo G
    J Virol; 2007 Dec; 81(24):13783-93. PubMed ID: 17913825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity.
    Sheridan DA; Bridge SH; Felmlee DJ; Crossey MM; Thomas HC; Taylor-Robinson SD; Toms GL; Neely RD; Bassendine MF
    J Hepatol; 2012 Jul; 57(1):32-8. PubMed ID: 22414761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis.
    Yee MS; Pavitt DV; Tan T; Venkatesan S; Godsland IF; Richmond W; Johnston DG
    J Lipid Res; 2008 Jun; 49(6):1364-71. PubMed ID: 18337616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.
    Diaz O; Delers F; Maynard M; Demignot S; Zoulim F; Chambaz J; Trépo C; Lotteau V; André P
    J Gen Virol; 2006 Oct; 87(Pt 10):2983-2991. PubMed ID: 16963757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.
    Roth D; Cirocco R; Zucker K; Ruiz P; Viciana A; Burke G; Carreno M; Esquenazi V; Miller J
    Transplantation; 1995 Jun; 59(12):1676-82. PubMed ID: 7541575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
    Triyatni M; Saunier B; Maruvada P; Davis AR; Ulianich L; Heller T; Patel A; Kohn LD; Liang TJ
    J Virol; 2002 Sep; 76(18):9335-44. PubMed ID: 12186916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of hepatitis C virus in human sera with beta-lipoprotein.
    Thomssen R; Bonk S; Propfe C; Heermann KH; Köchel HG; Uy A
    Med Microbiol Immunol; 1992; 181(5):293-300. PubMed ID: 1335546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles.
    Haid S; Pietschmann T; Pécheur EI
    J Biol Chem; 2009 Jun; 284(26):17657-67. PubMed ID: 19411248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection.
    Sheridan DA; Hajarizadeh B; Fenwick FI; Matthews GV; Applegate T; Douglas M; Neely D; Askew B; Dore GJ; Lloyd AR; George J; Bassendine MF; Grebely J
    Liver Int; 2016 Dec; 36(12):1774-1782. PubMed ID: 27224844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.
    Baumert TF; Ito S; Wong DT; Liang TJ
    J Virol; 1998 May; 72(5):3827-36. PubMed ID: 9557666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological identification of hepatitis C virus E1 and E2 envelope glycoproteins on the virion surface using immunogold electron microscopy.
    Kaito M; Watanabe S; Tanaka H; Fujita N; Konishi M; Iwasa M; Kobayashi Y; Gabazza EC; Adachi Y; Tsukiyama-Kohara K; Kohara M
    Int J Mol Med; 2006 Oct; 18(4):673-8. PubMed ID: 16964422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein.
    Craig WY; Nutik R; Cooper AD
    J Biol Chem; 1988 Sep; 263(27):13880-90. PubMed ID: 2843542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.
    Hijikata M; Shimizu YK; Kato H; Iwamoto A; Shih JW; Alter HJ; Purcell RH; Yoshikura H
    J Virol; 1993 Apr; 67(4):1953-8. PubMed ID: 8383220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor.
    Owen DM; Huang H; Ye J; Gale M
    Virology; 2009 Nov; 394(1):99-108. PubMed ID: 19751943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enveloped particles in the serum of chronic hepatitis C patients.
    Petit MA; Lièvre M; Peyrol S; De Sequeira S; Berthillon P; Ruigrok RW; Trépo C
    Virology; 2005 Jun; 336(2):144-53. PubMed ID: 15892956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.
    Voisset C; Callens N; Blanchard E; Op De Beeck A; Dubuisson J; Vu-Dac N
    J Biol Chem; 2005 Mar; 280(9):7793-9. PubMed ID: 15632171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus.
    Monazahian M; Kippenberger S; Müller A; Seitz H; Böhme I; Grethe S; Thomssen R
    Med Microbiol Immunol; 2000 Jun; 188(4):177-84. PubMed ID: 10917154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells.
    Borén J; Rustaeus S; Olofsson SO
    J Biol Chem; 1994 Oct; 269(41):25879-88. PubMed ID: 7929292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus particle detected by immunoelectron microscopic study.
    Kaito M; Watanabe S; Tsukiyama-Kohara K; Yamaguchi K; Kobayashi Y; Konishi M; Yokoi M; Ishida S; Suzuki S; Kohara M
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1755-60. PubMed ID: 7517432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody.
    Pumeechockchai W; Bevitt D; Agarwal K; Petropoulou T; Langer BC; Belohradsky B; Bassendine MF; Toms GL
    J Med Virol; 2002 Nov; 68(3):335-42. PubMed ID: 12226819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.